Results
1 -
2 of
2Bürli Roland W., Luckhurst Christopher A., Aziz Omar, Matthews Kim L., Yates Dawn, Lyons Kathy. A., Beconi Maria, McAllister George, Breccia Perla, Stott Andrew J., Penrose Stephen D., Wall Michael, Lamers Marieke, Leonard Philip, Müller Ilka, Richardson Christine M., Jarvis Rebecca, Stones Liz, Hughes Samantha, Wishart Grant, Haughan Alan F., O’Connell Catherine, Mead Tania, McNeil Hannah, Vann Julie, Mangette John, Maillard Michel, Beaumont Vahri, Munoz-Sanjuan Ignacio, Dominguez Celia.
Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease, Journal of Medicinal Chemistry, 2013 Lobera et al.
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group.
Nature Chemical Biology, doi: 10.1038/nchembio.1223, published online 24 March 2013
http://www.nature.com/naturechemicalbiology, Nature Chemical Biology